IGC Pharma, Inc. (IGC)

Last Closing Price: 0.20 (2026-11-18)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

IGC Pharma, Inc. (IGC) had Earnings per Share (EPS) (Diluted) of $-0.02 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$0.33M
$-2.05M
$0.27M
$0.06M
$2.26M
$-1.93M
$-0.12M
$-2.05M
$-2.05M
$-2.05M
$-2.05M
$-2.05M
$-2.05M
$-1.93M
$-1.87M
109.49M
109.49M
$-0.02
Earnings per Share (EPS) (Diluted)
$-0.02
Balance Sheet Financials
$1.31M
$2.03M
$8.42M
$9.73M
$3.10M
$0.13M
$0.13M
$3.23M
$6.50M
$0.76M
$6.50M
114.35M
Cash Flow Statement Financials
$-3.99M
$-0.62M
$4.11M
$0.90M
$0.38M
$-0.52M
$2.15M
--
--
Fundamental Metrics & Ratios
0.42
--
--
0.02
0.13
18.60%
-588.72%
-588.72%
--
-623.78%
-623.78%
$-4.00M
--
--
--
0.03
0.42
4.82
18.66
-31.47%
-268.86%
-21.03%
-30.86%
$0.06
$-0.04
$-0.04